Study reveals stark contrast: Novo Nordisk's Ozempic diabetes drug costs nearly $1,000 monthly in the U.S., yet could be produced for less than $5. This underscores the affordability challenge faced by patients amid soaring demand and insurers dropping coverage.
CENTENNIAL, CO / ACCESSWIRE / September 28, 2023 / NioCorp Developments Ltd. ("NioCorp" or the "Company") (NASDAQ:NB)(TSX:NB) plans to make aluminum-scandium master alloy product ("Al-Sc
Hudson Global Inc (NASDAQ:HSON) has acquired Hunt & Badge Consulting Private Limited, an India-headquartered provider of recruitment services to customers…